12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Company News  |  Sales & Marketing

NaPro, F. H. Faulding & Co. Ltd. sales and marketing update

NPRO expanded the companies' 1995 marketing deal under which Faulding has rights to market NPRO's paclitaxel in Australia and certain countries in...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >